# Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Prevalence Study (GPS)

> **NCT01914003** · — · COMPLETED · sponsor: **QOL Medical, LLC** · enrollment: 53 (actual)

## Conditions studied

- Congenital Sucrase-isomaltase Deficiency (CSID)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01914003
- **Lead sponsor:** QOL Medical, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2015-05
- **Final completion:** 2015-07
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2017-11-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01914003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01914003, "Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Prevalence Study (GPS)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01914003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*